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Darwin F Yeung1* and Rose Hsu1,2Abstract
Various paraneoplastic autoimmune phenomena have been reported in patients with myelodysplastic syndromes. We
describe a patient who developed expressive aphasia as a paraneoplastic complication of chronic myelomonocytic
leukemia (CMML). Awareness of the various possible manifestations of CMML may aid in the early recognition of
the condition.
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Chronic myelomonocytic leukemia (CMML) is a clonal
hematopoietic stem cell disorder that exhibits both
myelodysplastic and myeloproliferative features and is
characterized by persistent absolute monocytosis (Parikh
and Tefferi 2013). Median survival ranges from 10 to
32 months (Patnaik et al. 2013). Diagnosis may be aided
by awareness of its various manifestations, including
autoimmune paraneoplastic phenomena (Saif et al.
2002; Enright et al. 1995; Craig and Lin 2013; Fleming
et al. 2012; Lemasle et al. 2010; Messiaen et al. 1996).
We describe a patient with expressive aphasia as the
presenting symptom of CMML.Case description
A 64-year-old previously healthy woman presented to
hospital in October 2011 with loss of consciousness,
expressive aphasia, and left lower extremity numbness.
Exam revealed left lower extremity involuntary movements
as well as fluent aphasia with paraphasic errors, impaired
comprehension, impaired reading, and preserved writing.
Computed tomography (CT), magnetic resonance imaging
(MRI), and electroencephalography (EEG) were unre-
markable. Her symptoms resolved without intervention
within days. She began a trial of phenytoin for presumed
seizures but discontinued it shortly after discharge due
to intolerance.* Correspondence: darwin.yeung@alumni.ubc.ca
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(hemoglobin 8.8 g/dL (range 12.0-15.0), mean corpuscular
volume (MCV) 74 fL (range 82–98)), thrombocytopenia
(platelet count 107 × 109/L (range 150–400)), normal
white blood cell (WBC) count (7.4 × 109/L (range 4.0-
10.5)) and monocytosis (1.10 × 109/L (range 0.10-0.80)).
Her anemia had been present for over a decade but had
not been investigated by a bone marrow biopsy.
Four months later, she re-presented with aphasia, con-
fusion, headache, and left-sided numbness that gradually
resolved without intervention. She lost 18 kg since her
last admission. CT, MRI, and EEG now showed a sub-
acute left cerebellar infarct but no other abnormalities.
Investigations revealed persistent microcytic anemia,
thrombocytopenia, and monocytosis, along with neutro-
philia (6.99 × 109/L, range 2.00-6.00) and an enlarged
spleen (13.5 × 13 × 11 cm). A bone marrow biopsy and
cytogenetic analysis demonstrated panhyperplasia and no
detectable clonal abnormality. She was discharged on
gabapentin for presumed seizures.
Two months later, her aphasia returned with accompany-
ing pericardial effusion, biopsy-proven leptomeningeal
inflammation, and left elbow arthritis responsive to
prednisone. Rheumatoid factor was transiently elevated
at 21.8 IU/mL (range 0.0-20.0). She developed severe
leukocytosis (WBC 75.1 × 109/L) from neutrophilia
(54.82 × 109/L) and monocytosis (11.26 × 109/L). How-
ever, repeat bone marrow biopsy revealed only reactive
hyperplasia. Her gapapentin was replaced with valproic
acid, methotrexate, and a tapering dose of prednisone.is an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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of aphasia but failed to thrive due to an enlarging
spleen (25 × 16 × 12 cm). A third bone marrow biopsy
in September 2013, after two years of investigation,
demonstrated CMML. She started hydroxyurea to reduce
the size of her spleen and discontinued prednisone and
methotrexate given her neurological remission.
Two months after diagnosis, she was re-admitted for a
fourth episode of aphasia that resolved after the reinsti-
tution of prednisone. Given the substantial morbidity
from her massive spleen, she underwent a splenectomy.
Unfortunately, she developed respiratory failure due in
part to leukostasis (WBC 253.4 × 109/L) and died on the
second post-operative day.
Discussion
To our knowledge, this is the first reported case of
CMML presenting with expressive aphasia. Its recurrence
during disease progression along with its responsiveness
to steroids support it being a paraneoplastic autoimmune
complication. Previously reported neurologic manifesta-
tions of CMML include Guillain-Barre syndrome (del
Campo Fernández et al. 2001), IgA-related polyneuropathy
(Maeda et al. 1989), and acute and chronic inflammatory
demyelinating polyneuropathies (Konstadoulakis et al.
1993; Isoda et al. 2009) peripherally, as well as seizures
(Enright et al. 1995), right hemiparesis (Takubo et al.
1998), meningeal inflammation (Aoyama et al. 2003;
Ohno et al. 1988), suprachoroidal hemorrhage (Shaikh
et al. 2002), pseudotumor inflammatory lesions (Joubert
et al. 2013), and anterior ischemic optic neuropathy
(De Smit and O’Sullivan 2013) centrally. Awareness of
the various manifestations of the condition, including
aphasia, however rare, will hopefully alert clinicians of
CMML as a diagnostic possibility.
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